Love Maharashtra? Then you wil love Marathikatta!
Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                    Movies   Aviation   Pharma   About Us   Feedback   Links

Bangladesh to set up API park; to export drugs worth Tk 8.50 cr to Burma

March 25, 2006

The government of Bangladesh would soon establish industrial parks for the pharmaceutical sector with assistance from the World Bank (WB), official sources said. 

A cluster of manufacturing units for active pharmaceuticals ingredients (API) would be set up under the project. However, the locations for Pharmaceuticals Ingredients Park is yet to be selected.

The Bangladesh government has asked the WB to provide funds for establishing three industrial parks, including one for the garment sector and the WB has agreed in principle to finance the project worth US$150 million, according to officials from Board of Investments. 

The government is expected to sign an agreement to this effect with the WB in June this year. 

Meanwhile, Bangladesh's pharmaceuticals industry received export orders worth Tk 8.50 crore from Burma at Pharmaceuticals fair in Rangoon, Burma, a report of BD News said.

The export order was received through Edruc Limited for Tk 7 crore while Beximco Pharma got orders for the remaining Tk 1.50 crore.

The deal was forged at a recent 3-day Pharmaceuticals fair was jointly organized by Export Promotion Bureau (EPB) of Bangladesh and Bangladesh Embassy in Burma, exclusively for Bangladesh's pharmaceutical products.

A total of 25 pharmaceutical firms, including Renata Limited, Global Capsules Limited, Biopharma Laboratories Limited, General Pharmaceuticals Limited, Beximco Pharmaceuticals Limited and Edruc Limited took part in the fair.

Burma imports 85 per cent of pharmaceuticals items from Bangladesh.

More related stories from Pharma

Healing prayers no cure for the ill, says study

Pulmonary hypertension drug PulmoLAR in human trial

Pharma markets in China, Korea, Mexico, Russia & Turkey gather pace

Pfizerís anxiety drug Lyrica gets EU nod

Asymmetrical breasts: A presage to cancer?

Dream to eradicate polio still far off

GlaxoSmithKline loses fluticasone case

Able files recast plan with bankruptcy court

Ranbaxy in pact with Zenotech on cancer drugs

Lupin and Aspen to form JV on TB drugs

Blood cancer drug Ceflatonin gets orphan drug status

Bangladesh to set up API park; to export drugs worth Tk 8.50 cr to Burma

Wockhard Limited: A profile
Cipla Ltd company profile




Auto news for auto freaks!
DWS community! / Cricket blog


Latest Stories in Pharma

 Vertex commences phase II studies for Aurora kinase inhibitor VX-680

GlaxoSmithKline starts H5N1 avian flu vaccine trials in Germany, Belgium

Novartis acquires rights for two drug leads

Serono plans major acquisitions

Samaritan to sell Amphocil in Greece

HIV infection cases fall in South India

Flu drug: Erimos, NC State University seek patent for EM-1421

HollisterStier inks pact with Prism Pharma on cardiovascular drug PM101

Erbitux approved for head and neck cancer in Europe

EPIX Pharmaceuticals merges with Predix

Avanir's involuntary emotional expression disorder (IEED) drug Neurodex gets priority review

 Death of women raises alarm on abortion pillís safety

Prestwick gets approvable letter for Xenazine for treatment of chorea with HD

Nexavar - Kidney cancer drug gets Swiss nod

Anti-rejection drug Prograf approved in US


Latest Stories in Pharma

Archived Pharma stories


Latest updates    Contact Us - Feedback    About Us